Divergent Standard Care Makes Full EU Regulator/HTA Harmony Unlikely
This article was originally published in The Pink Sheet Daily
Executive Summary
While EU regulators and HTA bodies are coming together on major drug development criteria, differing standard care regimes across the 28 European Union member states makes real harmonization seem far off.